FI915148A - Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. - Google Patents

Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. Download PDF

Info

Publication number
FI915148A
FI915148A FI915148A FI915148A FI915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A
Authority
FI
Finland
Prior art keywords
och
bensimidazole
bensimidazolderivat
indol
imidazol
Prior art date
Application number
FI915148A
Other languages
English (en)
Other versions
FI915148A0 (fi
Inventor
Michael Anthony Poss
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI915148A0 publication Critical patent/FI915148A0/fi
Publication of FI915148A publication Critical patent/FI915148A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
FI915148A 1990-10-31 1991-10-31 Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. FI915148A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60663190A 1990-10-31 1990-10-31

Publications (2)

Publication Number Publication Date
FI915148A0 FI915148A0 (fi) 1991-10-31
FI915148A true FI915148A (fi) 1992-05-01

Family

ID=24428787

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915148A FI915148A (fi) 1990-10-31 1991-10-31 Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat.

Country Status (23)

Country Link
EP (1) EP0488532A1 (fi)
JP (1) JPH0592969A (fi)
KR (1) KR920008032A (fi)
CN (1) CN1061224A (fi)
AU (1) AU650294B2 (fi)
CA (1) CA2054594A1 (fi)
CS (1) CS330591A3 (fi)
EG (1) EG19826A (fi)
FI (1) FI915148A (fi)
HU (1) HU214575B (fi)
IE (1) IE913785A1 (fi)
IL (1) IL99917A0 (fi)
MX (1) MX9101873A (fi)
MY (1) MY108611A (fi)
NO (1) NO180749C (fi)
NZ (1) NZ240383A (fi)
PH (1) PH31175A (fi)
PL (1) PL168902B1 (fi)
PT (1) PT99404A (fi)
RO (1) RO109735B1 (fi)
RU (1) RU2111208C1 (fi)
YU (1) YU173791A (fi)
ZA (1) ZA918688B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
GB9113626D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic compounds
GB9113628D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic derivatives
KR0156948B1 (ko) * 1992-03-25 1998-11-16 가와노 다께히꼬 이소인다졸 화합물
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
AU658729B2 (en) * 1992-03-27 1995-04-27 Kyoto Pharmaceutical Industries, Ltd. 3-(1H-imidazol-1-ylmethyl)-1H-indole derivatives
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
CN101006053A (zh) 2004-06-18 2007-07-25 比奥里波克斯公司 用于治疗炎症的吲哚
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
BRPI0511834A (pt) 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
AU2005275182A1 (en) 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating Hepatitis C
ATE501119T1 (de) 2005-01-19 2011-03-15 Biolipox Ab Entzündungshemmende indol-derivate
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103965167A (zh) * 2013-01-29 2014-08-06 通化济达医药有限公司 咪唑羧酸衍生物
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
CN106397414A (zh) * 2015-08-14 2017-02-15 陈志龙 杂螺环酮吲哚衍生物的一种制备方法
CN113999204B (zh) * 2021-11-08 2023-09-05 常州大学 一种非手性咪唑型离子化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8820231D0 (en) * 1988-08-25 1988-09-28 Fujisawa Pharmaceutical Co New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Also Published As

Publication number Publication date
PL168902B1 (pl) 1996-05-31
KR920008032A (ko) 1992-05-27
RO109735B1 (ro) 1995-05-30
PT99404A (pt) 1992-09-30
AU650294B2 (en) 1994-06-16
HU913418D0 (en) 1992-01-28
RU2111208C1 (ru) 1998-05-20
NO180749C (no) 1997-06-11
NO914263L (no) 1992-05-04
EP0488532A1 (en) 1992-06-03
NO180749B (no) 1997-03-03
CA2054594A1 (en) 1992-05-01
NO914263D0 (no) 1991-10-30
MY108611A (en) 1996-10-31
IE913785A1 (en) 1992-05-22
PH31175A (en) 1998-03-20
ZA918688B (en) 1992-08-26
JPH0592969A (ja) 1993-04-16
CS330591A3 (en) 1992-06-17
FI915148A0 (fi) 1991-10-31
HUT59677A (en) 1992-06-29
MX9101873A (es) 1992-06-05
YU173791A (sh) 1994-01-20
IL99917A0 (en) 1992-08-18
EG19826A (en) 1996-03-31
HU214575B (hu) 1998-04-28
PL292249A1 (en) 1992-07-13
CN1061224A (zh) 1992-05-20
NZ240383A (en) 1994-12-22
AU8691091A (en) 1992-05-07

Similar Documents

Publication Publication Date Title
FI915148A (fi) Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat.
FI912703A0 (fi) Vaesentlig fettsyrabehandling.
DE69112037D1 (de) Waferträger.
FI914843A (fi) Submarint produktionssystem.
DE69111876D1 (de) Ophthalmometer.
FI86244B (fi) Bakugn-spisugnkombination.
FI86263B (fi) Skaer- och slipanordning foer en glasskivkant.
FI87009B (fi) Skovelhjul foer centrifugalpumpar.
FI900062A (fi) Spelanordning.
DE69110728D1 (de) 8-Sulfamylmethylen-2-aminotetraline.
FI900028A0 (fi) Belaeggningsmaterial.
DE69104797T2 (de) 2-Substituierte-1-Hydroxyindole.
FI902305A0 (fi) Laddningssystem.
FI900061A0 (fi) Spelanordning.
FI900060A0 (fi) Vinstfoerdelningsport foer en spelanordning.
ES1015245Y (es) Traca mejorada.
ES1014027Y (es) Anillo-reten mejorado.
ES1013945Y (es) Humectador-aromatizador.
ES1014067Y (es) Caja-expositor.
ES1014804Y (es) Auto-caravana independizable.
ES1019974Y (es) Capazo-cuna.
ES1017193Y (es) Cubre-bidet.
ES1015228Y (es) Kiosko.
ES1015089Y (es) Muneco caricatura titere.
ES1015059Y (es) Capsula-tapa.